Monochorionic monoamniotic twins : the most precarious of twin pregnanciesDØRUM, A; NESHEIM, B.-I.Acta obstetricia et gynecologica Scandinavica. 1991, Vol 70, Num 4-5, pp 381-383, issn 0001-6349Article

Oral contraceptives and the risk of hereditary ovarian cancerNAROD, S. A; RISCH, H; BRUNET, J.-S et al.The New England journal of medicine. 1998, Vol 339, Num 7, pp 424-428, issn 0028-4793Article

A randomised study of cisplatin versus thiotepa as induction chemotherapy in advanced ovarian carcinomaDØRUM, A; KRISTENSEN, G. B; TROPE, C et al.European journal of cancer. Part A. 1994, Vol 30, Num 10, pp 1470-1474Article

Clinical implications of BRCA1 genetic testingDØRUM, A; HEIMDAL, K; MØLLER, P et al.Acta obstetricia et gynecologica Scandinavica. 1998, Vol 77, Num 4, pp 458-461, issn 0001-6349Article

Inherited predisposition to breast carcinoma. Results of first round examination of 537 women at riskSAETERSDAL, A; DØRUM, A; HEIMDAL, K et al.Anticancer research. 1996, Vol 16, Num 4A, pp 1989-1992, issn 0250-7005Article

Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation techniqueMONSTAD, S. E; STORSTEIN, A; DØRUM, A et al.Clinical and experimental immunology (Print). 2006, Vol 144, Num 1, pp 53-58, issn 0009-9104, 6 p.Article

Early detection of familial ovarian cancerDØRUM, A; KRISTENSEN, G. B; ABELER, V. M et al.European journal of cancer (1990). 1996, Vol 32, Num 10, pp 1645-1651, issn 0959-8049Article

Prospectively detected cancer in familial breast/ovarian cancer screeningDØRUM, A; HEIMDAL, K; SHETELIG, K et al.Acta obstetricia et gynecologica Scandinavica. 1999, Vol 78, Num 10, pp 906-911, issn 0001-6349Article

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutationsBORG, A; DØRUM, A; HEIMDAL, K et al.Disease markers. 1999, Vol 15, Num 1-3, pp 79-84, issn 0278-0240Article

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancersEVANS, D. G; GAARENSTROOM, K. N; VASEN, H. F. A et al.Journal of medical genetics. 2009, Vol 46, Num 9, pp 593-597, issn 0022-2593, 5 p.Article

The problem of skipped generation and subclinical disease in familial breast-ovarian cancerDØRUM, A; ABELER, V. M; HEIMDAL, K et al.Acta obstetricia et gynecologica Scandinavica. 1997, Vol 76, Num 2, pp 166-168, issn 0001-6349Article

Evaluation of endometrial thickness measured by endovaginal ultrasound in women with postmenopausal bleedingDØRUM, A; KRISTENSEN, G. B; LANGEBREKKE, A et al.Acta obstetricia et gynecologica Scandinavica. 1993, Vol 72, Num 2, pp 116-119, issn 0001-6349Article

Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancerDØRUM, A; HEIMDAL, K; HOVIG, E et al.American journal of human genetics. 1999, Vol 65, Num 3, pp 671-679, issn 0002-9297Article

Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insADØRUM, A; HOVIG, E; TROPE, C et al.European journal of cancer (1990). 1999, Vol 35, Num 5, pp 779-781, issn 0959-8049Article

Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene statusSMITH-SØRENSEN, B; KAERN, J; HOLM, R et al.British journal of cancer. 1998, Vol 78, Num 3, pp 375-381, issn 0007-0920Article

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testingDØRUM, A; MØLLER, P; VAN DER MEULEN, M. A et al.European journal of cancer (1990). 1997, Vol 33, Num 14, pp 2390-2392, issn 0959-8049Article

Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-studyKURTZ, J. E; KAMINSKY, M. C; SCAMBIA, G et al.Annals of oncology. 2011, Vol 22, Num 11, pp 2417-2423, issn 0923-7534, 7 p.Article